22 Jul 2026Open access
Revisiting autologous stem cell transplantation for LBCL in the CAR T-Cell eraPublisher siteHematology/Oncology and Stem Cell Therapy, CAR-T cell therapy research
Active, last published 2026
In acute lymphoblastic leukemia research
Ahmed Kotb
Abdrabou
Scholar“Research focused on Acute Lymphoblastic Leukemia research and adjacent fields.”
Zagazig University
Egypt
Claim Your ProfileEgypt2
H-index
18
Citations
Ahmed has not officially claimed their profile. If you are Ahmed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
hmed Kotb Abdrabou is a researcher working on Acute Lymphoblastic Leukemia research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ahmed's work has been cited 18 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Acute Lymphoblastic Leukemia research×11Acute Myeloid Leukemia Research×4Childhood Cancer Survivors' Quality of Life×4Chronic Myeloid Leukemia Treatments×4CAR-T cell therapy research×4
04 · Where I am
Affiliations
Affiliation on published researchZagazig University, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
7 works1 Jun 2026
Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicityPublisher siteTransplantation and Cellular Therapy, Hematopoietic Stem Cell Transplantation
13 Apr 2026Open access
Asciminib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Case Series and Review of Emerging EvidencePublisher siteHematology Reports, Chronic Myeloid Leukemia Treatments
1 Mar 2026Open access
Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Induction: The End of Story or Not Yet?Publisher siteTechnology in Cancer Research & Treatment, Acute Myeloid Leukemia Research
26 Aug 2024
ALL-151 Impact of Blinatumomab on Survival Outcomes in Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell ALL Following the Initial Phase of Pediatric-Inspired Chemotherapy: A Comparative StudyPublisher siteClinical Lymphoma Myeloma & Leukemia, Acute Lymphoblastic Leukemia research
26 Aug 2024
Impact of Blinatumomab on Survival Outcomes in Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell ALL Following the Initial Phase of Pediatric-Inspired Chemotherapy: A Comparative StudyPublisher siteClinical Lymphoma Myeloma & Leukemia, Chronic Myeloid Leukemia Treatments
1 Mar 2024Open access
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patientsPublisher siteAnnals of Saudi Medicine, Multiple Myeloma Research and Treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ahmed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you